Excel Industries reports Q4FY26 revenue growth, declares dividend
Excel Industries reported a 13% year-on-year increase in standalone revenue to INR281 crores for Q4FY26, with profit after tax rising to INR13 crores. For FY26, net operating revenues grew 11.8% to INR1,094 crores, and adjusted EBITDA stood at INR112 crores. The Board declared a final dividend of INR13.75 per share. The company remains net cash positive and identified Performance Solutions, YP Derivatives, and Contract Manufacturing as key growth drivers for FY27.

*this image is generated using AI for illustrative purposes only.
Excel Industries reported a 13% year-on-year increase in standalone revenue to INR281 crores for Q4FY26, compared to INR248 crores in the corresponding period of the previous year. Profit after tax for the quarter rose to INR13 crores from INR11 crores in Q4FY25. For the full financial year FY26, the company recorded net operating revenues of INR1,094 crores, a growth of 11.8% over FY25, with a profit after tax of INR73 crores. The Board has declared a final dividend of INR13.75 per equity share, which is 275% of the face value of INR5 per share.
Financial Performance
The adjusted EBITDA for Q4FY26 stood at INR22 crores, an increase of 13% year-on-year, with margins at 8%. For FY26, adjusted EBITDA was INR112 crores with margins of 10.1%. The company maintains a zero long-term debt position and is net cash positive, which it stated provides a cushion to weather operational challenges and invest in strategic initiatives.
| Metric | Q4FY26 | Q4FY25 | FY26 | FY25 |
|---|---|---|---|---|
| Revenue (INR crores) | 281 | 248 | 1,094 | 978 |
| Adjusted EBITDA (INR crores) | 22 | 20 | 112 | - |
| Adjusted EBITDA Margin (%) | 8 | - | 10.1 | - |
| Profit After Tax (INR crores) | 13 | 11 | 73 | - |
Business Updates
Management noted that the first half of FY26 was challenging for the agrochemical sector due to an extended monsoon, but demand improved in Q4FY26. A capacity addition of 2,530 tons per annum in the biocides range became operational in the second half of FY26. The company also operationalized a new corporate R&D center at Rabale, Navi Mumbai. A contract manufacturing agreement with a multinational company is progressing, with capacity expected to come on stream in July 2026.
Outlook
The company indicated that while raw material availability and prices pose challenges for Q1, it has managed to pass on price increases. Growth drivers for FY27 are identified as Performance Solutions, YP Derivatives, and Contract Manufacturing. The company plans to launch a new biocide product in the second half of the financial year.
Historical Stock Returns for Excel Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.63% | +2.14% | -5.80% | +0.62% | -25.77% | -14.64% |
How will the new contract manufacturing capacity coming online in July 2026 impact revenue diversification?
What is the expected revenue contribution from the new biocide product launching in the second half of FY27?
Will the company leverage its net cash position for further strategic acquisitions or capacity expansions?


































